Form 4 for LAB STANDARD BIOTOOLS INC.
Accepted 2022-06-17 00:00:00 ET · period of report 2022-06-15 · accession 0001162194-22-000076 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-06-17 | 2022-06-15 | LAB | Casdin Eli | Dir | A - Grant | $0.00 | +30.9K | 46.8K | +195% | $0 |
| D | 2022-06-17 | 2022-06-15 | LAB | Casdin Eli | Dir | A - Grant | $1.86 | +42.6K | 42.6K | New | +$79.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-06-15 | A | A | 30,914 | $0.00 | 46,766 | D | — | — | (F1) Represents Restricted Stock Units that vest in full on the earlier to occur of June 15, 2023 and one day prior to the date of the Issuer's next annual meeting of stockholders. |
| 2 | Derivative | Stock Option (Right to Buy) | 2022-06-15 | A | A | 42,571 | $1.86 | 42,571 | D | $1.86 · — to 2032-06-15 | 42,571 Common Stock | (F2) The Option becomes exercisable in twelve equal monthly increments beginning on July 15, 2022. |